SonoWorld.com uses cookies to improve your experience on the site. Your continued use of the site constitutes your acceptance of use of cookies on this site.
Find out more about how SonoWorld uses cookies. I’m OK with Cookies from SonoWorld - stop showing me this banner.
×
 
175,643 Registered Members as of 08/24/2019.
Jill E. Langer, MD
The Role of Genetic Testing in the Evaluation of Thyroid Nodules
Jill E. Langer, MD
09/13/2015 | Time : 35 min
About This Lecture:

The speaker discusses how analysis of the molecular composition of thyroid nodules aids in the diagnosis of thyroid cancer. Upon completion of this educational activity the participant will be able to employ methods of molecular analysis to better classify malignant and benign thyroid nodules.

Topics mentioned in this video : Thyroid cancer overview,Bethesda classification,Atypia /follicular lesion of undetermined significance ,Indeterminate FNA,Oncogene analysis,RNA expression test

To view this lecture video, Login or register for a free membership below ↓
Already a Member? Login
 
 
Forgot username or password?
Register for Your FREE Membership Now!
Sign Up In Less Than One Minute
  • UNLOCK access to SonoWorld lectures, articles, cases, and more
  • Full Access Membership is FREE
  • You will have IMMEDIATE access on submitting the Membership form
  • JOIN the world's largest community of ultrasound professionals

* *
* *
* *
*
*
*
Review the SonoWorld Privacy Policy here.
Weekly Update Newsletter :
New Products and Services :
        Terms & Conditions         Privacy Policy

Keywords : Afirma ™, atypia of undetermined significance, AUS, BRAF mutations, fine needle aspiration, FLUS, FNA, follicular cancer, follicular lesion of undetermined significance, indeterminate thyroid cytology, papillary cancer, RNA expression, thyroid cancer, thyroid cytology, total thyroidectomy

IE Browser Compatibility Close